List of works - Chantal Attard

Beta (β)-antithrombin activity in children and adults: implications for heparin therapy in infants and children

scientific article published on 19 June 2014

Body Composition in Young Adults Living With a Fontan Circulation: The Myopenic Profile

scientific article published on 15 April 2020

Cardiopulmonary bypass changes the plasma proteome in children undergoing tetralogy of Fallot repair

scientific article published on 6 January 2015

Comment on: Generation and optimization of the self-administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease

scientific article published on 20 July 2017

Cross-sectional assessment of haemostatic profile and hepatic dysfunction in Fontan patients

scientific article published in May 2021

Development and Validation of the Warfarin-Aspirin Bleeding Assessment Tool (WA-BAT) in Children

scientific article published on 27 June 2019

Developmental haemostasis: age-specific differences in the quantity of hemostatic proteins: reply to a rebuttal.

scientific article published in February 2014

Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults.

scientific article

Differences in the resting platelet proteome and platelet releasate between healthy children and adults

scientific article published on 11 April 2015

Epidemiology of venous thrombosis in children with cancer

scientific article published on 13 February 2014

Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial model

scientific article published in May 2022

First report of elevated monocyte-platelet aggregates in healthy children

scientific article

Impact of adiposity on clinical outcomes in people living with a Fontan circulation

scientific article published on 30 December 2020

Increased Risk for Thromboembolism After Fontan Surgery: Considerations for Thromboprophylaxis

scientific article published in 2022

Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts

scientific article published in October 2021

Investigating potential protein markers of cardiovascular disease in children with type 1 diabetes mellitus

scientific article published on 16 April 2021

Latent Antithrombin Levels in Children and Adults ⬇️

scientific article published on 04 December 2012

Letter to the Editor regarding ‘effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma’ ⬇️

scientific article published on 01 September 2012

Long-term outcomes of warfarin versus aspirin after Fontan surgery

scientific article published in October 2021

Neurocognitive Dysfunction and Smaller Brain Volumes in Adolescents and Adults with a Fontan Circulation

scientific article published on 24 November 2020

No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients

scientific article

Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C

scientific article published on 02 May 2022

Pathophysiology of thrombosis and anticoagulation post Fontan surgery

scientific article published on 14 April 2018

Personalised anticoagulation approach to improve the prevention and treatment of thrombosis

scientific article published on 02 April 2014

Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity

scientific article

Platelets from children are hyper-responsive to activation by thrombin receptor activator peptide and adenosine diphosphate compared to platelets from adults

scientific article

Prevalence and risk factors for low bone density in adults with a Fontan circulation

scientific article published on 20 August 2019

Primary Thromboprophylaxis in Children with Cancer: A Road Less Travelled

scientific article published on 05 December 2019

Proteomics in Thrombosis and Hemostasis

scientific article published on 9 November 2021

Remote ischemic preconditioning (RIPC) modifies the plasma proteome in children undergoing repair of tetralogy of fallot: a randomized controlled trial

scientific article

The impact of cardiopulmonary bypass on factor XIII levels in children

scientific article published on 29 August 2012

The in vitro anticoagulant effect of rivaroxaban in children

scientific article published on 11 August 2012

The in-vitro anticoagulant effect of rivaroxaban in neonates

scientific article published on 01 April 2014

The microparticle-specific procoagulant phospholipid activity changes with age.

scientific article published on 4 September 2013

List of works by Chantal Attard

Beta (β)-antithrombin activity in children and adults: implications for heparin therapy in infants and children

Body Composition in Young Adults Living With a Fontan Circulation: The Myopenic Profile

Cardiopulmonary bypass changes the plasma proteome in children undergoing tetralogy of Fallot repair

Comment on: Generation and optimization of the self-administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease

Cross-sectional assessment of haemostatic profile and hepatic dysfunction in Fontan patients

Development and Validation of the Warfarin-Aspirin Bleeding Assessment Tool (WA-BAT) in Children

Developmental haemostasis: age-specific differences in the quantity of hemostatic proteins: reply to a rebuttal.

Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults.

Differences in the resting platelet proteome and platelet releasate between healthy children and adults

Epidemiology of venous thrombosis in children with cancer

Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial model

First report of elevated monocyte-platelet aggregates in healthy children

Impact of adiposity on clinical outcomes in people living with a Fontan circulation

Increased Risk for Thromboembolism After Fontan Surgery: Considerations for Thromboprophylaxis

Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts

Investigating potential protein markers of cardiovascular disease in children with type 1 diabetes mellitus

Latent Antithrombin Levels in Children and Adults ⬇️

Letter to the Editor regarding ‘effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma’ ⬇️

Long-term outcomes of warfarin versus aspirin after Fontan surgery

Neurocognitive Dysfunction and Smaller Brain Volumes in Adolescents and Adults with a Fontan Circulation

No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients

Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C

Pathophysiology of thrombosis and anticoagulation post Fontan surgery

Personalised anticoagulation approach to improve the prevention and treatment of thrombosis

Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity

Platelets from children are hyper-responsive to activation by thrombin receptor activator peptide and adenosine diphosphate compared to platelets from adults

Prevalence and risk factors for low bone density in adults with a Fontan circulation

Primary Thromboprophylaxis in Children with Cancer: A Road Less Travelled

Proteomics in Thrombosis and Hemostasis

Remote ischemic preconditioning (RIPC) modifies the plasma proteome in children undergoing repair of tetralogy of fallot: a randomized controlled trial

The impact of cardiopulmonary bypass on factor XIII levels in children

The in vitro anticoagulant effect of rivaroxaban in children

The in-vitro anticoagulant effect of rivaroxaban in neonates

The microparticle-specific procoagulant phospholipid activity changes with age.